Pages that link to "Q31847067"
Jump to navigation
Jump to search
The following pages link to Mutant huntingtin enhances excitotoxic cell death. (Q31847067):
Displaying 50 items.
- Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1 (Q24310249) (← links)
- Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder (Q24626017) (← links)
- Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? (Q26770781) (← links)
- Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus (Q28505053) (← links)
- Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease (Q28507781) (← links)
- Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease (Q28589793) (← links)
- SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington's disease (Q29994841) (← links)
- Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease (Q30501273) (← links)
- Stem Cells Transplantation and Huntington's Disease (Q33614689) (← links)
- Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions (Q33914031) (← links)
- Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death (Q33949349) (← links)
- Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. (Q34071987) (← links)
- Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease (Q34126315) (← links)
- FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease (Q34212651) (← links)
- Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned? (Q34284039) (← links)
- Huntington's disease: new hope for therapeutics (Q34553826) (← links)
- Lessons from animal models of Huntington's disease (Q34586943) (← links)
- Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases (Q34606186) (← links)
- Role of Inositol 1,4,5-Trishosphate Receptors in Pathogenesis of Huntington’s Disease and Spinocerebellar Ataxias (Q34981549) (← links)
- The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. (Q35031245) (← links)
- The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration (Q36045254) (← links)
- Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease (Q36276521) (← links)
- Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells (Q36519737) (← links)
- Selective neuronal degeneration in Huntington's disease (Q36597920) (← links)
- Mitochondrial nuclear receptors and transcription factors: who's minding the cell? (Q37015652) (← links)
- Stem cell-based cell therapy for Huntington disease: a review (Q37028233) (← links)
- Inositol 1,4,5-tripshosphate receptor, calcium signaling, and polyglutamine expansion disorders (Q37201299) (← links)
- Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration (Q37237452) (← links)
- Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease (Q37349826) (← links)
- The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start? (Q37441183) (← links)
- Huntington's disease and Group I metabotropic glutamate receptors (Q37820343) (← links)
- Pathogenic Mechanisms in Huntington's Disease (Q37930038) (← links)
- A mitochondrial basis for Huntington's disease: therapeutic prospects (Q38174451) (← links)
- Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium (Q38603960) (← links)
- Attenuation of low dose methylmercury and glutamate induced‐cytotoxicity and tau phosphorylation by an N‐methyl‐D‐aspartate antagonist in human neuroblastoma (SHSY5Y) cells (Q39462697) (← links)
- Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease (Q39573183) (← links)
- Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain. (Q39691379) (← links)
- Excitotoxicity effects of glutamate on human neuroblastoma SH-SY5Y cells via oxidative damage (Q39747906) (← links)
- Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease. (Q39804344) (← links)
- Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease. (Q40149501) (← links)
- Disrupted spermine homeostasis: a novel mechanism in polyglutamine-mediated aggregation and cell death. (Q40526299) (← links)
- Adenosine as a neuroprotectant: therapeutic perspectives (Q40657295) (← links)
- Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line (Q40682294) (← links)
- Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. (Q40704833) (← links)
- Modulation of NMDA-mediated excitotoxicity by protein kinase C. (Q40783952) (← links)
- Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease (Q42465415) (← links)
- Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease (Q42525075) (← links)
- Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease (Q43120924) (← links)
- Hunting for excitement: NMDA receptors in Huntington's disease (Q43925464) (← links)
- Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease (Q43925468) (← links)